Chinese Pharma Looks To Out-Licensing As Domestic Downturn Bites

lifeline and straws to clutch at
struggling Chinese drug makers scramble for licensing deals amid economic downturn • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia